3Jaakskelainen J,Haltia M,Servo A.Atypical and anaplastic meningiomas:radiology,surgery,radiotherapy and outcome[J].Surg Neurol,1986,25:233～242.
4Katz TS,Amdur RJ,Yachnis AT,et al.Pushing the limits of radiotherapy for atypical and malignant meningioma[J].Am J Clin Oncol,2005,28(1):70～74.
5von Randow AJ,Schindler S,Tews DS.Expression of extracellular matrixdegrading proteins in classic,atypical,and anaplastic meningiomas[J].Pathol Res Pract,2006,202(5):365～372.
6Okuducu AF,Zils U,Michaelis SA,et al.Ets-1 is up-regulated together with its target gene products matrix metalloproteinase-2 and matrix metalloproteinase-9 in atypical and anaplastic meningiomas[J].Histopathology,2006,48(7):836～845.
7Arslantas A,Artan S,Oner U,et al.Comparative genomic hybridization analysis of genomic alterations in benign,atypical and anaplastic meningiomas[J].Acta Neurol Belg,2002,102(2):53～62.
8Ozen O,Demirhan B,Altinors N.Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas[J].Clin Neuropathol,2005,24(5):219～224.
9Nagashima G,Aoyagi M,Yamamoto S,et al.Involvement of disregulated c-myc but not c-sis/PDGF in atypical and anaplastic meningiomas[J].Clin Neurol Neurosurg,2001,103(1):13～18.
10Yamasaki F,Yoshioka H,Hama S,et al.Recurrence of meningiomas[J].Cancer,2000,89(5):1102～1110.
